{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:03:30Z","timestamp":1776877410307,"version":"3.51.2"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/mt.2016.32","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T15:11:05Z","timestamp":1454685065000},"page":"877-889","source":"Crossref","is-referenced-by-count":36,"title":["Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN Deficiency"],"prefix":"10.1016","volume":"24","author":[{"given":"Yurika","family":"Katsu-Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frida","family":"Lor\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"D\u00edaz-Nido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.32_bib1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/jnc.12317","article-title":"Clinical features of Friedreich's ataxia: classical and atypical phenotypes","volume":"126(Suppl 1)","author":"Parkinson","year":"2013","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2016.32_bib2","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1177\/0883073812448230","article-title":"Clinical features of Friedreich ataxia","volume":"27","author":"Delatycki","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1038\/mt.2016.32_bib3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1177\/0883073812453498","article-title":"Unanswered questions in Friedreich ataxia","volume":"27","author":"Lynch","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1038\/mt.2016.32_bib4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.brainresrev.2011.04.001","article-title":"Friedreich's ataxia: past, present and future","volume":"67","author":"Marmolino","year":"2011","journal-title":"Brain Res Rev"},{"key":"10.1038\/mt.2016.32_bib5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/NEN.0b013e31827e5762","article-title":"Friedreich ataxia: neuropathology revised","volume":"72","author":"Koeppen","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2016.32_bib6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrg1691","article-title":"Diseases of unstable repeat expansion: mechanisms and common principles","volume":"6","author":"Gatchel","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1038\/mt.2016.32_bib7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1086\/301680","article-title":"The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure","volume":"62","author":"Bidichandani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1038\/mt.2016.32_bib8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/jnc.12254","article-title":"Gene regulation and epigenetics in Friedreich's ataxia","volume":"126(Suppl 1)","author":"Yandim","year":"2013","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2016.32_bib9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng0897-345","article-title":"Studies of human, mouse and yeast homologues indicate a mitochondrial function for FXN","volume":"16","author":"Koutnikova","year":"1997","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2016.32_bib10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.1098991","article-title":"FXN acts as an iron chaperone protein to modulate mitochondrial aconitase activity","volume":"305","author":"Bulteau","year":"2004","journal-title":"Science"},{"key":"10.1038\/mt.2016.32_bib11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/jnc.12220","article-title":"FXN: a protein in search for a function","volume":"126(r 1)","author":"Pastore","year":"2013","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2016.32_bib12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fphar.2014.00029","article-title":"Mitochondrial iron-sulfur cluster dysfunction in neurodegenerative disease","volume":"5","author":"Isaya","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1038\/mt.2016.32_bib13","first-page":"25","article-title":"Beyond loss of FXN: the complex molecular pathology of Friedreich ataxia","volume":"17","author":"Evans-Galea","year":"2014","journal-title":"Discov Med"},{"key":"10.1038\/mt.2016.32_bib14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jnc.12219","article-title":"Animal and cellular models of Friedreich ataxia","volume":"126(Suppl 1)","author":"Perdomini","year":"2013","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2016.32_bib15","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1093\/hmg\/ddr187","article-title":"Silencing of FXN gene expression triggers p53-dependent apoptosis in human neuron-like cells","volume":"20","author":"Palomo","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.32_bib16","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1093\/hmg\/ddu745","article-title":"Unveiling a common mechanism of apoptosis in \u03b2-cells and neurons in Friedreich's ataxia","volume":"24","author":"Igoillo-Esteve","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.32_bib17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2014.12.017","article-title":"FXN knockdown in human astrocytes triggers cell death and the release of factors that cause neuronal toxicity","volume":"76","author":"Lor\u00eda","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2016.32_bib18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1326-4-8","article-title":"The therapeutic importance of understanding mechanisms of neuronal cell death in neurodegenerative disease","volume":"4","author":"Golde","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.1038\/mt.2016.32_bib19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1586\/14737175.2014.939173","article-title":"Therapeutic approaches for the treatment of Friedreich's ataxia","volume":"14","author":"Strawser","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"10.1038\/mt.2016.32_bib20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ygeno.2015.05.006","article-title":"Delivery of the 135 kb human FXN genomic DNA locus gives rise to different FXN isoforms","volume":"106","author":"P\u00e9rez-Luz","year":"2015","journal-title":"Genomics"},{"key":"10.1038\/mt.2016.32_bib21","doi-asserted-by":"publisher","first-page":"14044","DOI":"10.1038\/mtm.2014.44","article-title":"An AAV9 coding for FXN clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models","volume":"1","author":"G\u00e9rard","year":"2014","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1038\/mt.2016.32_bib22","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/gt.2011.45","article-title":"Infectious delivery and long-term persistence of transgene expression in the brain by a 135-kb iBAC-FXN genomic DNA expression vector","volume":"18","author":"Gimenez-Cassina","year":"2011","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.32_bib23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nm.3510","article-title":"Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia","volume":"20","author":"Perdomini","year":"2014","journal-title":"Nat Med"},{"key":"10.1038\/mt.2016.32_bib24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/sj.mt.6300143","article-title":"Functional recovery in a Friedreich's ataxia mouse model by FXN gene transfer using an HSV-1 amplicon vector","volume":"15","author":"Lim","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.32_bib25","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1038\/mtna.2013.41","article-title":"A potential new therapeutic approach for Friedreich ataxia: induction of FXN expression with TALE proteins","volume":"2","author":"Chapdelaine","year":"2013","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1038\/mt.2016.32_bib26","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/mt.2015.41","article-title":"Excision of expanded GAA repeats alleviates the molecular phenotype of Friedreich's ataxia","volume":"23","author":"Li","year":"2015","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.32_bib27","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1098\/rstb.2006.1894","article-title":"Neurotrophin-regulated signalling pathways","volume":"361","author":"Reichardt","year":"2006","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1038\/mt.2016.32_bib28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","article-title":"GDNF, NGF and BDNF as therapeutic options for neurodegeneration","volume":"138","author":"Allen","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1038\/mt.2016.32_bib29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1474-4422(02)00006-6","article-title":"Growth-factor gene therapy for neurodegenerative disorders","volume":"1","author":"Tuszynski","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1038\/mt.2016.32_bib30","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/mds.21423","article-title":"Gene transfer therapy for neurodegenerative disorders","volume":"22","author":"Feigin","year":"2007","journal-title":"Mov Disord"},{"key":"10.1038\/mt.2016.32_bib31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.phrs.2009.10.002","article-title":"Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS","volume":"61","author":"Lim","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1038\/mt.2016.32_bib32","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1089\/hum.2014.003","article-title":"Transgenic expression of human glial cell line-derived neurotrophic factor from integration-deficient lentiviral vectors is neuroprotective in a rodent model of Parkinson's disease","volume":"25","author":"Lu-Nguyen","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.32_bib33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.brainres.2014.10.049","article-title":"Neurotrophic factors for spinal cord repair: which, where, how and when to apply, and for what period of time?","volume":"1619","author":"Harvey","year":"2015","journal-title":"Brain Res"},{"key":"10.1038\/mt.2016.32_bib34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s40266-014-0160-x","article-title":"Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease","volume":"31","author":"Rodrigues","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1038\/mt.2016.32_bib35","doi-asserted-by":"publisher","first-page":"601084","DOI":"10.1155\/2014\/601084","article-title":"Potential therapeutic effects of neurotrophins for acute and chronic neurological diseases","volume":"2014","author":"Cai","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1038\/mt.2016.32_bib36","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/cdd.2009.44","article-title":"Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes","volume":"16","author":"Galluzzi","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1038\/mt.2016.32_bib37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/156652321305131212123237","article-title":"Targeted delivery of growth factors by HSV-mediated gene transfer for peripheral neuropathy","volume":"13","author":"Chattopadhyay","year":"2013","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2016.32_bib38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.brainres.2006.05.023","article-title":"Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor","volume":"1101","author":"Serres","year":"2006","journal-title":"Brain Res"},{"key":"10.1038\/mt.2016.32_bib39","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"key":"10.1038\/mt.2016.32_bib40","first-page":"3976","article-title":"Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis","volume":"53","author":"Kaufmann","year":"1993","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2016.32_bib41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jneumeth.2013.12.004","article-title":"Generation of a neurodegenerative disease mouse model using lentiviral vectors carrying an enhanced synapsin I promoter","volume":"223","author":"Matsuzaki","year":"2014","journal-title":"J Neurosci Methods"},{"key":"10.1038\/mt.2016.32_bib42","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12311-012-0432-0","article-title":"Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology","volume":"12","author":"N\u00f3brega","year":"2013","journal-title":"Cerebellum"},{"key":"10.1038\/mt.2016.32_bib43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0166-2236(03)00164-4","article-title":"Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors","volume":"26","author":"Kirik","year":"2003","journal-title":"Trends Neurosci"},{"key":"10.1038\/mt.2016.32_bib44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/84818","article-title":"Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits","volume":"27","author":"Puccio","year":"2001","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2016.32_bib45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ygeno.2006.06.015","article-title":"GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology","volume":"88","author":"Al-Mahdawi","year":"2006","journal-title":"Genomics"},{"key":"10.1038\/mt.2016.32_bib46","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1242\/dmm.018952","article-title":"A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia","volume":"8","author":"Anjomani Virmouni","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1038\/mt.2016.32_bib47","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1523\/JNEUROSCI.4549-03.2004","article-title":"Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia","volume":"24","author":"Simon","year":"2004","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2016.32_bib48","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00401-011-0844-9","article-title":"The cerebellar component of Friedreich's ataxia","volume":"122","author":"Koeppen","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1038\/mt.2016.32_bib49","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/brain\/awv064","article-title":"Structural and functional MRI abnormalities of cerebellar cortex and nuclei in SCA3, SCA6 and Friedreich's ataxia","volume":"138","author":"Stefanescu","year":"2015","journal-title":"Brain"},{"key":"10.1038\/mt.2016.32_bib50","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00429-014-0931-5","article-title":"A neuronal aging pattern unique to humans and common chimpanzees","volume":"221","author":"Gilissen","year":"2016","journal-title":"Brain Struct Funct"},{"key":"10.1038\/mt.2016.32_bib51","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/brain\/awf184","article-title":"Neuronal intranuclear inclusions in a new cerebellar tremor\/ataxia syndrome among fragile X carriers","volume":"125","author":"Greco","year":"2002","journal-title":"Brain"},{"key":"10.1038\/mt.2016.32_bib52","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00401-002-0651-4","article-title":"Clinical and neuropathological correlates of Lewy body disease","volume":"105","author":"Hishikawa","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.1038\/mt.2016.32_bib53","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/0092-8674(94)90377-8","article-title":"Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development","volume":"76","author":"Jones","year":"1994","journal-title":"Cell"},{"key":"10.1038\/mt.2016.32_bib54","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/sj.mp.4000359","article-title":"Cerebellar pathology in BDNF\u2212\/\u2212 mice: the classic view of neurotrophins is changing","volume":"3","author":"Schwartz","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1038\/mt.2016.32_bib55","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: roles in neuronal development and function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1038\/mt.2016.32_bib56","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0736-5748(03)00086-8","article-title":"High affinity neurotrophin receptors in the human pre-term newborn, infant, and adult cerebellum","volume":"21","author":"Quartu","year":"2003","journal-title":"Int J Dev Neurosci"},{"key":"10.1038\/mt.2016.32_bib57","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1111\/bph.12531","article-title":"Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF?","volume":"171","author":"Markham","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1038\/mt.2016.32_bib58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yexcr.2015.04.013","article-title":"Novel aberrant genetic and epigenetic events in Friedreich's ataxia","volume":"335","author":"Quesada","year":"2015","journal-title":"Exp Cell Res"},{"key":"10.1038\/mt.2016.32_bib59","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.bbadis.2009.07.011","article-title":"FXN deficiency induces Schwann cell inflammation and death","volume":"1792","author":"Lu","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/mt.2016.32_bib60","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1093\/hmg\/ddu407","article-title":"FXN deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia","volume":"23","author":"Hayashi","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.32_bib61","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jns.2008.02.011","article-title":"Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis","volume":"270","author":"Makar","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1038\/mt.2016.32_bib62","doi-asserted-by":"publisher","first-page":"372423","DOI":"10.1155\/2010\/372423","article-title":"Effects of brain-derived neurotrophic factor on local inflammation in experimental stroke of rat","volume":"2010","author":"Jiang","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1038\/mt.2016.32_bib63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1742-2094-7-81","article-title":"Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures","volume":"7","author":"Bovolenta","year":"2010","journal-title":"J Neuroinflammation"},{"key":"10.1038\/mt.2016.32_bib64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1326-7-51","article-title":"FXN deficiency unveils cell-context dependent actions of insulin-like growth factor I on neurons","volume":"7","author":"Franco","year":"2012","journal-title":"Mol Neurodegener"},{"key":"10.1038\/mt.2016.32_bib65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2053-8871-1-10","article-title":"IGF-1 in Friedreich's Ataxia\u2014proof-of-concept trial","volume":"1","author":"Sanz-Gallego","year":"2014","journal-title":"Cerebellum Ataxias"},{"key":"10.1038\/mt.2016.32_bib66","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1089\/scd.2012.0029","article-title":"Human adipose stem cell-conditioned medium increases survival of Friedreich's ataxia cells submitted to oxidative stress","volume":"21","author":"Jones","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1038\/mt.2016.32_bib67","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/mt.2014.143","article-title":"Mesenchymal stem cells improve motor functions and decrease neurodegeneration in ataxic mice","volume":"23","author":"Jones","year":"2015","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.32_bib68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jphysparis.2011.11.003","article-title":"Herpes simplex virus type 1-based amplicon vectors for fundamental research in neurosciences and gene therapy of neurological diseases","volume":"106","author":"Jerusalinsky","year":"2012","journal-title":"J Physiol Paris"},{"key":"10.1038\/mt.2016.32_bib69","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2217\/pmt.11.49","article-title":"Gene therapy for pain: a perspective","volume":"1","author":"Fink","year":"2011","journal-title":"Pain Manag"},{"key":"10.1038\/mt.2016.32_bib70","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrneurol.2013.56","article-title":"Progress in gene therapy for neurological disorders","volume":"9","author":"Simonato","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1038\/mt.2016.32_bib71","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/hum.2014.2501","article-title":"Herpes simplex viral vectors: late bloomers with big potential","volume":"25","author":"Glorioso","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.32_bib72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12990-015-0018-1","article-title":"Current gene therapy using viral vectors for chronic pain","volume":"11","author":"Guedon","year":"2015","journal-title":"Mol Pain"},{"key":"10.1038\/mt.2016.32_bib73","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ymthe.2006.05.019","article-title":"In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration","volume":"14","author":"Buch","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.32_bib74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/156652309787354649","article-title":"Gene therapy approaches to ataxias","volume":"9","author":"Lim","year":"2009","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2016.32_bib75","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1089\/hum.2013.180","article-title":"Cell and gene therapy for Friedreich ataxia: progress to date","volume":"25","author":"Evans-Galea","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.32_bib76","first-page":"259","article-title":"HIV-based vectors. Preparation and use","volume":"69","author":"Follenzi","year":"2002","journal-title":"Methods Mol Med"},{"key":"10.1038\/mt.2016.32_bib77","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1006\/mthe.2001.0294","article-title":"Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome","volume":"3","author":"Saeki","year":"2001","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2016.32_bib78","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1126\/science.2843986","article-title":"A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons","volume":"241","author":"Geller","year":"1988","journal-title":"Science"},{"key":"10.1038\/mt.2016.32_bib79","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1097\/00001756-199611250-00062","article-title":"HSV-1 vector mediated transfer of BDNF into cerebellar granule cells","volume":"7","author":"Alonso","year":"1996","journal-title":"Neuroreport"},{"key":"10.1038\/mt.2016.32_bib80","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1006\/mcne.1996.0017","article-title":"Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons","volume":"7","author":"Goodman","year":"1996","journal-title":"Mol Cell Neurosci"},{"key":"10.1038\/mt.2016.32_bib81","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1523\/JNEUROSCI.04-08-01944.1984","article-title":"An electron microscopic study of the development of axons and dendrites by hippocampal neurons in culture. I. Cells which develop without intercellular contacts","volume":"4","author":"Bartlett","year":"1984","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2016.32_bib82","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0091-679X(08)61930-5","article-title":"Calcium, free radicals, and excitotoxic neuronal death in primary cell culture","volume":"46","author":"Mattson","year":"1995","journal-title":"Methods Cell Biol"},{"key":"10.1038\/mt.2016.32_bib83","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1387-2656(05)11004-7","article-title":"Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction","volume":"11","author":"Berridge","year":"2005","journal-title":"Biotechnol Annu Rev"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T01:02:07Z","timestamp":1600131727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616302155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1525001616302155"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.32","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}